CIANCIOTTI, BEATRICE CLAUDIA
 Distribuzione geografica
Continente #
EU - Europa 69
NA - Nord America 35
AS - Asia 32
Totale 136
Nazione #
IT - Italia 43
US - Stati Uniti d'America 35
SE - Svezia 16
CN - Cina 15
SG - Singapore 8
JP - Giappone 4
IE - Irlanda 3
IL - Israele 3
RU - Federazione Russa 3
DE - Germania 2
FI - Finlandia 1
FR - Francia 1
HK - Hong Kong 1
IR - Iran 1
Totale 136
Città #
Milan 24
Ashburn 8
Rome 6
Shanghai 6
Singapore 5
Lawrence 4
Princeton 4
Dublin 3
Ibaraki 3
Kfar Saba 3
Boardman 2
Brembate di Sopra 2
Chaoyang 2
Chengdu 2
Cittadella 2
Moscow 2
New York 2
San Giovanni Lupatoto 2
Washington 2
Central 1
Dallas 1
Helsinki 1
Ikoma 1
Jiaxing 1
Kashan 1
Legnano 1
Monza 1
San Francisco 1
Seattle 1
Shenzhen 1
Totale 95
Nome #
Revealing and harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells 50
CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function 33
CD4+ Memory Stem T Cells Recognizing Citrullinated Epitopes Are Expanded in Patients With Rheumatoid Arthritis and Sensitive to Tumor Necrosis Factor Blockade 21
Flow cytometry data mining by cytoChain identifies determinants of exhaustion and stemness in TCR-engineered T cells 20
TCR Redirected T Cells for Cancer Treatment: Achievements, Hurdles, and Goals 14
TIM-3, LAG-3, or 2B4 gene disruptions increase the anti-tumor response of engineered T cells 6
HARNESSING CD39 FOR THE TREATMENT OF COLORECTAL CANCER AND LIVER METASTASES BY ENGINEERED T CELLS 2
Harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells 2
Totale 148
Categoria #
all - tutte 1.657
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.657


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 0 0 0 0 0 1 0 0
2020/20211 0 0 0 0 0 1 0 0 0 0 0 0
2021/202216 0 0 0 1 1 0 0 1 4 1 3 5
2022/202332 8 8 4 1 1 4 0 0 2 3 0 1
2023/202462 3 1 11 8 4 6 6 8 0 4 3 8
2024/202536 9 6 10 8 3 0 0 0 0 0 0 0
Totale 148